Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Context Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CNTX.
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
Other companies in Context Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Bioage Labs (NASDAQ:BIOA), Universe Pharmaceuticals (NASDAQ:UPC) and Rani Therapeutics Hldgs (NASDAQ:RANI).
Context Therapeutics has a consensus price target of $6.50.
The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.863 last updated March 26, 2025 at 10:14 AM EDT.
There are no upcoming dividends for Context Therapeutics.
Context Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Context Therapeutics.
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.